News Daily News ABC-Bleeding Score Stratifies Risk in A-fib Patients on OAC and Aspirin Todd Neale September 21, 2020
News Conference News ESC 2020 Got Mail? Letter-Based Intervention Doesn’t Boost OAC Initiation for A-fib Todd Neale September 03, 2020
News Daily News Simple MIRACLE2 Score Could Help Triage Out-of-Hospital Cardiac Arrest Shelley Wood August 05, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Daily News Ablation Cuts A-fib Recurrences, Burden Through 5 Years in CABANA Todd Neale June 23, 2020
News Daily News Racial, Ethnic Minorities Largely Left Out of Major A-fib Trials Todd Neale June 16, 2020
News Daily News Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19 Michael O'Riordan May 26, 2020
News Conference News HRS 2020 Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’ Michael O'Riordan May 21, 2020
News Conference News HRS 2020 Micra Leadless Pacemaker Tied to Fewer Complications in Medicare Patients Todd Neale May 18, 2020
News Daily News Infection Risk No Higher With Recycled Pacemakers, Defibrillators L.A. McKeown May 07, 2020
News Features Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance Shelley Wood April 29, 2020
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Conference News ACC 2020 LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout Todd Neale April 06, 2020
News Conference News ACC 2020 Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS Todd Neale April 03, 2020
News Conference News ACC 2020 Low Mortality Rates Seen With Andexanet Alfa for Factor Xa-Related Bleeds Todd Neale March 25, 2020
News Daily News More Support for DOAC-Based Double Therapy After PCI for A-fib Patients Todd Neale March 16, 2020
News Opinion Editor's Corner A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out Shelley Wood March 16, 2020
News Daily News Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban Todd Neale March 09, 2020